Abstract: A control method for a refrigerator and a refrigerator are provided. The refrigerator includes a compartment, an evaporator, and a heating module. The method includes: acquiring a current temperature of the compartment; and adjusting an operating power of the heating module according to the current temperature, so that the heating module heats the compartment to a target temperature according to the operating power, where different temperature ranges correspond to different operating powers.

Abstract: A refrigerator and an anti-condensation method for the refrigerator. The refrigerator includes a first storage compartment, a second storage compartment adjacent the first storage compartment, a separation wall separating the first storage compartment and the second storage compartment, and a heater in the separation wall. The first storage compartment is adapted to be set at a refrigerating temperature, and the second storage compartment is adapted to be set at a freezing temperature. In the anti-condensation method, the heater is controlled to work in an anti-condensation mode when a refrigeration system stops cooling the first storage compartment, to heat a surface of the separation wall facing the first storage compartment, which can significantly reduce the probability of condensation on the surface and is beneficial to reduce the impact of the working of the heater on the refrigeration system.

Abstract: A method for operating a refrigeration appliance includes the steps of running a compressor and opening at least one of a first branch and a second branch, where the first branch has a first evaporator, the second branch has a second evaporator, and the first branch and the second branch are connected in parallel at inlets thereof. The method further determines, according to an ambient temperature, whether the first branch is open after the compressor is turned off and determines, based on the ambient temperature, whether the second branch is open after the compressor is turned off.

Abstract: A control method for a refrigerator and a refrigerator are provided. The refrigerator includes a compartment, an evaporator, and a heating module. The method includes: acquiring a current temperature of the compartment; and adjusting an operating power of the heating module according to the current temperature, so that the heating module heats the compartment to a target temperature according to the operating power, where different temperature ranges correspond to different operating powers.

Abstract: Compositions are directed to BCL2-associated athanogene 3 (BAG3) molecules and agents which modulate expression of BAG3 molecules. Pharmaceutical composition for administration to patients, for example, patients with heart failure, comprise one or more BAG3 molecules or agents which modulate expression of BAG3. Methods of treatment and identifying candidate therapeutic agents are also provided.

Abstract: Compositions are directed to BCL2-associated athanogene 3 (BAG3) molecules and agents which modulate expression of BAG3 molecules. Pharmaceutical composition for administration to patients, for example, patients with heart failure, comprise one or more BAG3 molecules or agents which modulate expression of BAG3. Methods of treatment and identifying candidate therapeutic agents are also provided.

Abstract: Compositions are directed to BCL2-associated athanogene 3 (BAG3) molecules and agents which modulate expression of BAG3 molecules. Pharmaceutical composition for administration to patients, for example, patients with heart failure, comprise one or more BAG3 molecules or agents which modulate expression of BAG3. Methods of treatment and identifying candidate therapeutic agents are also provided.

Abstract: A method for operating a refrigeration appliance includes the steps of running a compressor and opening at least one of a first branch and a second branch, where the first branch has a first evaporator, the second branch has a second evaporator, and the first branch and the second branch are connected in parallel at inlets thereof. The method further determines, according to an ambient temperature, whether the first branch is open after the compressor is turned off and determines, based on the ambient temperature, whether the second branch is open after the compressor is turned off.

Abstract: Compositions are directed to BCL2-associated athanogene 3 (BAG3) molecules and agents which modulate expression of BAG3 molecules. Pharmaceutical composition for administration to patients, for example, patients with heart failure, comprise one or more BAG3 molecules or agents which modulate expression of BAG3. Methods of treatment and identifying candidate therapeutic agents are also provided.

Abstract: A diarization embodiment may include a system that clusters data up to a current point in time and consolidates it with the past decisions, and then returns the result that minimizes the difference with past decisions. The consolidation may be achieved by performing a permutation of the different possible labels and comparing the distance. For speaker diarization, a distance may be determined based on a minimum edit or hamming distance. The distance may alternatively be a measure other than the minimum edit or hamming distance. The clustering may have a finite time window over which the analysis is performed.

Abstract: This disclosure concerns the discovery of (R,R)- and (R,S)-fenoterol analogues which are highly effective at binding ?2-adrenergic receptors. Exemplary chemical structures for these analogues are provided. Also provided are pharmaceutical compositions including the disclosed (R,R)-fenoterol and fenoterol analogues, and methods of using such compounds and compositions for the treatment of cardiac disorders such as congestive heart failure and pulmonary disorders such as asthma or chronic obstructive pulmonary disease.

Abstract: This disclosure concerns the discovery of (R,R)- and (R,S)-fenoterol analogues which are highly effective at binding ?2-adrenergic receptors. Exemplary chemical structures for these analogues are provided. Also provided are pharmaceutical compositions including the disclosed (R,R)-fenoterol and fenoterol analogues, and methods of using such compounds and compositions for the treatment of cardiac disorders such as congestive heart failure and pulmonary disorders such as asthma or chronic obstructive pulmonary disease.

Abstract: This disclosure concerns the discovery of (R,R)- and (R,S)-fenoterol analogs which are highly effective at binding ?2-adrenergic receptors. Exemplary chemical structures for these analogs are provided. Also provided are pharmaceutical compositions including the disclosed (R,R)-fenoterol and fenoterol analogs, and methods of using such compounds and compositions for the treatment of cardiac disorders such as congestive heart failure and pulmonary disorders such as asthma or chronic obstructive pulmonary disease.

Abstract: Embodiments of the present invention provide a computer-implemented method for communicating a reference code for a transaction. The method monitors a communication session conducted between a user and an agent via a communication channel, extracts user and channel properties from the monitored communication session, selects a reference code from a set of references codes stored on a database, in which the selection is based at least in part on the extracted communication channel properties and the extracted user properties, and then communicates the selected reference code to the user.

Abstract: Embodiments of the present invention provide a computer-implemented method for communicating a reference code for a transaction. The method monitors a communication session conducted between a user and an agent via a communication channel, extracts user and channel properties from the monitored communication session, selects a reference code from a set of references codes stored on a database, in which the selection is based at least in part on the extracted communication channel properties and the extracted user properties, and then communicates the selected reference code to the user.

Abstract: Embodiments of the invention include method, systems and computer program products for role modeling. Aspects of the invention include receiving, by a processor, audio data, wherein the audio data includes a plurality of audio conversation for one or more speakers. The one or more segments for each of the plurality of audio conversations are partitioned. A speaker is associated with each of the one or more segments. The one or more segments for each of the plurality of audio conversations are labeled with roles utilizing a speaker recognition engine. Speakers are clustered based at least in part on a number of times the speakers are present in an audio conversation.

Abstract: Embodiments of the invention include method, systems and computer program products for role modeling. Aspects of the invention include receiving, by a processor, audio data, wherein the audio data includes a plurality of audio conversation for one or more speakers. The one or more segments for each of the plurality of audio conversations are partitioned. A speaker is associated with each of the one or more segments. The one or more segments for each of the plurality of audio conversations are labeled with roles utilizing a speaker recognition engine. Speakers are clustered based at least in part on a number of times the speakers are present in an audio conversation.

Abstract: A diarization embodiment may include a system that clusters data up to a current point in time and consolidates it with the past decisions, and then returns the result that minimizes the difference with past decisions. The consolidation may be achieved by performing a permutation of the different possible labels and comparing the distance. For speaker diarization, a distance may be determined based on a minimum edit or hamming distance. The distance may alternatively be a measure other than the minimum edit or hamming distance. The clustering may have a finite time window over which the analysis is performed.

Abstract: This disclosure concerns the discovery of (R,R)- and (R,S)-fenoterol analogues which are highly effective at binding ?2-adrenergic receptors. Exemplary chemical structures for these analogues are provided. Also provided are pharmaceutical compositions including the disclosed (R,R)-fenoterol and fenoterol analogues, and methods of using such compounds and compositions for the treatment of cardiac disorders such as congestive heart failure and pulmonary disorders such as asthma or chronic obstructive pulmonary disease.

Abstract: This disclosure concerns the discovery of (R,R)- and (R,S)-fenoterol analogs which are highly effective at binding ?2-adrenergic receptors. Exemplary chemical structures for these analogs are provided. Also provided are pharmaceutical compositions including the disclosed (R,R)-fenoterol and fenoterol analogs, and methods of using such compounds and compositions for the treatment of cardiac disorders such as congestive heart failure and pulmonary disorders such as asthma or chronic obstructive pulmonary disease.